Showing results (1851-1860 of 2,141) with videos related to

Sort By:
Pageof 215
Pharmacology, Biochemistry, and Behavior|July 5, 2021
Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in miceFan Zhang, Todd M Hillhouse, Paige M Anderson, et al.
Therapeutic Advances in Psychopharmacology|April 28, 2023
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case seriesFemin Prasad, Riddhita De, Vittal Korann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2002
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039Keith Chirgwin, Richard Hafner, Catherine Leport, et al.
Psychiatry Research. Neuroimaging|February 8, 2018
Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability studyEric Plitman, Sofia Chavez, Shinichiro Nakajima, et al.
The Journal of Pain|June 16, 2023
Covariate Adjustment in Chronic Pain Trials: An Oft-Missed OpportunityDale J Langford, Sonia Sharma, Michael P McDermott, et al.
Physical Review Letters|August 8, 2009
Observation of a Kelvin-helmholtz instability in a high-energy-density plasma on the omega laserE C Harding, J F Hansen, O A Hurricane, et al.
Expert Opinion on Drug Safety|November 27, 2019
The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacyKenya A Costa-Dookhan, Sri Mahavir Agarwal, Araba Chintoh, et al.
Cell Host & Microbe|July 7, 2021
Host-emitted amino acid cues regulate bacterial chemokinesis to enhance colonizationCatherine D Robinson, Emily G Sweeney, Julia Ngo, et al.
Frontiers in Immunology|December 28, 2023
A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumorsShawn Iadonato, Yulia Ovechkina, Kurt Lustig, et al.
Frontiers in Immunology|February 7, 2024
Corrigendum: A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumorsShawn Iadonato, Yulia Ovechkina, Kurt Lustig, et al.
Pageof 215